Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
暂无分享,去创建一个
K. D. Sørensen | H. Brenner | T. Rebbeck | R. Eeles | Z. Kote-Jarai | G. Giles | M. Guy | G. Severi | K. Muir | J. Hopper | B. Henderson | C. Haiman | J. Schleutker | F. Hamdy | D. Neal | J. Donovan | J. Stanford | E. Ostrander | S. Ingles | S. Thibodeau | Jong Y. Park | A. Spurdle | J. Clements | J. Dickinson | C. Maier | K. Cooney | L. Cannon-Albright | P. Chappuis | P. Hutter | M. Zeegers | R. Kaneva | Hong-wei Zhang | Yong-jie Lu | W. Foulkes | D. Leongamornlert | M. Tymrakiewicz | R. Wilkinson | E. Saunders | E. Sawyer | M. Southey | A. Cox | L. FitzGerald | S. Chambers | J. Batra | D. Easton | P. Pharoah | A. Antoniou | F. Schumacher | B. Nordestgaard | T. Habuchi | S. Benlloch | T. Dadaev | K. Govindasami | N. Pashayan | Maren Weischer | K. Herkommer | A. Rinckleb | C. Cybulski | R. Stephenson | T. Orntoft | C. Zeigler-Johnson | A. Amin Al Olama | T. Doerk | Aritaya Lophatonanon | S. J. Little | Yong-jie Lu
[1] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[2] Peter Kraft,et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer , 2014, Nature Genetics.
[3] Nilanjan Chatterjee,et al. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies , 2013, Nature Genetics.
[4] Peter Kraft,et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.
[5] Suzanne Chambers,et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study , 2011, Nature Genetics.
[6] D. English,et al. A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact , 2011, Genetic epidemiology.
[7] Martin Eklund,et al. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. , 2011, European urology.
[8] D. Easton,et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening , 2011, British Journal of Cancer.
[9] Mads Thomassen,et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. , 2010, Cancer research.
[10] R. Eeles,et al. The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine , 2010, PloS one.
[11] D. English,et al. Prostate cancer segregation analyses using 4390 families from UK and Australian population‐based studies , 2009, Genetic epidemiology.
[12] Ali Amin Al Olama,et al. Multiple loci on 8q24 associated with prostate cancer susceptibility , 2009, Nature Genetics.
[13] Ali Amin Al Olama,et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study , 2009, Nature Genetics.
[14] Kevin M. Bradley,et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer , 2008, Nature Genetics.
[15] W. Willett,et al. Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.
[16] Ali Amin Al Olama,et al. Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.
[17] D. Gudbjartsson,et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.
[18] D. Gudbjartsson,et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.
[19] A. Whittemore,et al. Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.
[20] A. Gylfason,et al. A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.
[21] D. Easton,et al. EMGM Abstracts , 2003, Genetic epidemiology.
[22] N E Day,et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.